I disagree. I think she is a great asset. Wait, what was the question again?
Seriously though I doubt she has any inside info. More like connecting dots and throwing everything against the wall. She may be right but it would be more like pure luck.
I do think there is plenty of interest out there though. It will come down to the study results in my opinion. Because the tech is so modular, if the pill relieves pain and naltrexone is sequestered Elite is a must have for many of these Pharmas that have nothing in the field or want to expand their IP. I think we all probably believe that though.
Market Data 
Markets 
AI
